Elderflower contains flavonoles, the most important of them being quercetin. These molecules have an important antioxidant effect. The goal of our study was to evaluate which conservation technique of elderflower results the highest concentration of rutin and and phenolic compounds. Further we evaluated the protective effects of these extracts against nephrotoxicity induced by gentamicin in rats. Sambucus nigra extract demonstrates nephroprotective effects in gentamicin-induced renal toxicity, significantly improving outcome and evolution in rats.

Osteoarthritis is a common condition in dogs, particularly affecting elderly individuals, and the chronic pain it causes significantly impacts the quality of life of affected dogs. First, we will focus on the joint, the physiopathology of osteoarthritis, and the mechanisms of arthritic pain production, and then discuss the existing treatments. There are numerous treatments available for managing this complex osteoarticular condition, but unconventional therapies are increasingly of interest to owners of canine species. Phytotherapy harnesses the healing properties of plants for treatment in a less toxic, more natural, and more cost-effective manner, offering a wide range of therapeutic options for animals. The objective of this review is to evaluate the present evidence backing treatments for canine osteoarthritis. This includes non-steroidal anti-inflammatory drugs, piprants, monoclonal antibodies, adjunctive analgesics, structuremodifying osteoarthritis drugs, phytotherapy, and regenerative therapies.

Background: Ultrasound-guided kidney biopsy is an essential diagnostics method that can increase the accuracy of the differential diagnosis between acute and chronic nephropathies. In addition, it will help clinicians perform an etiologic diagnosis, issue a prognosis, and orient therapy for the majority of parenchymal nephropathies. Due to the relative invasiveness and potential adverse effects, the use of kidney biopsies is limited among practitioners. Results: Twenty-eight dogs, of mixed breed and variable ages, of which 11 (39, 29%) were males and 17 (60, 71%) were females, were examined and underwent an ultrasound-guided kidney biopsy to establish a definitive diagnosis. The patients were presented with a variety of diffuse nephropathies, such as kidney lymphoma: 1 (3.57%), glomerulonephritis: 13 (46.43%), tubulointerstitial nephritis: 11 (39.29%), and nephrocalcinosis. A total of 3 (10.71%) of 18 (64.29%) were in acute kidney injury, and 10 (35.71%) were CKD patients. The type and the severity of the kidney lesions were correlated with changes in the urinary n-acetyl-beta-d-glucosaminidase index (iNAG. To quantify the side effects of percutaneous kidney biopsy, the magnitude of post-biopsy hematuria and changes in urinary iNAG activity were evaluated. The results indicate a significant post-biopsy increase in the urinary iNAG activity in all the patients that underwent this procedure (100.08 ± 34.45 U/g), with a pre-biopsy iNAG vs. 147.65 ± 33.26 U/g post-biopsy iNAG (p < 0.001), suggesting an intensification in the kidney tubular damage that comes consecutives to kidney puncture and sampling. Transitory macro- or microhematuria were constant findings in all the dogs that underwent ultrasound-guided kidney biopsy, but the magnitude and extent could not be associated with the platelet count (PLT 109/L), aPTT (s), and PT (s) levels in our patients, and they were also resolved after 12–24 h without therapeutic interventions. Conclusions: Ultrasound-guided renal biopsy was shown to be a minimally invasive diagnostic procedure that causes transient and limited effects on kidney structures. Although these effects were minor and resolved without intervention, we feel that the benefit of obtaining higher-quality biopsied tissue outweighs the higher risks associated with this procedure.

Background: The role of bacterial infection in canine extrahepatic biliary disease remains inconsistently characterized. This retrospective case series evaluated associations between ultrasonographic gallbladder findings and bile culture results in dogs. Materials and Methods: Sixty-seven dogs were screened between March 2024 and December 2025, of which 49 met inclusion criteria (clinical, biochemical, and ultrasonographic evidence of gallbladder disease) and underwent bile sampling by ultrasound-guided cholecystocentesis (n = 45) or intraoperative collection (n = 4). Samples were cultured aerobically and anaerobically; isolates identified by MALDI-TOF MS were further tested for in vitro antimicrobial susceptibility using Kirby–Bauer disk diffusion method. Results: Among the 49 included dogs, ultrasonography identified cholecystitis (75.5%), cholelithiasis (16.3%), and biliary mucocele (8.2%). Bile cultures were positive in 43/49 dogs (87.8%), yielding only aerobic bacteria. Escherichia coli (46.5%) and coagulase-positive Staphylococci (30.2%) were most frequently isolated organisms. However, these findings should be interpreted cautiously due to small subgroup sizes and the exploratory nature of the analysis. Conclusions: In this selected referral population, bacterial isolates were frequently recovered from bile samples, particularly in dogs with cholecystitis. Prospective studies involving larger populations are warranted to confirm these results, define the bacterial prevalence and clinical significance of bacterial colonization or infection, and further refine evidence-based diagnostic and treatment strategies for dogs with extrahepatic biliary disease.

Serum creatinine (sCr), blood urea nitrogen (BUN) and symmetric dimethylarginine (SDMA) reflect glomerular filtration only and are subject to non-renal confounders including lean body mass, limiting early detection of renal dysfunction in geriatric dogs. We evaluated serum cystatin C (sCysC) and the urinary N-acetyl-β-D-glucosaminidase-to-creatinine ratio (NAG index) as early renal markers in healthy geriatric dogs. Sixty-one neutered geriatric dogs, free of clinical disease and of extrarenal laboratory abnormalities, were stratified into three groups: controls (n = 36), subclinical (normal sCr, ≥1 elevated biomarker; n = 17) and azotaemic chronic kidney disease (CKD; sCr > 1.5 mg/dL; n = 8). sCysC was measured by a canine-specific ELISA and the NAG index by colorimetric assay. Of the 61 dogs, 17 (27.9%) had at least one elevated biomarker with normal sCr, and all 17 also had normal BUN, indicating pre-azotaemic changes identified predominantly by sCysC. The NAG index was elevated in 6/17 (35.3%) subclinical dogs and SDMA in none (0/17). Because sCysC status partly informed group allocation and no independent measure of glomerular filtration rate was obtained, these findings characterise an altered renal biochemical phenotype rather than establish diagnostic accuracy, and require prospective validation.